These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. C3H/HeN mouse model for the evaluation of antiviral agents for the treatment of Venezuelan equine encephalitis virus infection. Julander JG; Skirpstunas R; Siddharthan V; Shafer K; Hoopes JD; Smee DF; Morrey JD Antiviral Res; 2008 Jun; 78(3):230-41. PubMed ID: 18313150 [TBL] [Abstract][Full Text] [Related]
25. Antibody Preparations from Human Transchromosomic Cows Exhibit Prophylactic and Therapeutic Efficacy against Venezuelan Equine Encephalitis Virus. Gardner CL; Sun C; Luke T; Raviprakash K; Wu H; Jiao JA; Sullivan E; Reed DS; Ryman KD; Klimstra WB J Virol; 2017 Jul; 91(14):. PubMed ID: 28468884 [TBL] [Abstract][Full Text] [Related]
26. Interplay of acute and persistent infections caused by Venezuelan equine encephalitis virus encoding mutated capsid protein. Atasheva S; Krendelchtchikova V; Liopo A; Frolova E; Frolov I J Virol; 2010 Oct; 84(19):10004-15. PubMed ID: 20668087 [TBL] [Abstract][Full Text] [Related]
27. Homoseongomycin, a compound isolated from marine actinomycete bacteria K3-1, is a potent inhibitor of encephalitic alphaviruses. Lin SC; Lehman CW; Stewart AK; Panny L; Bracci N; Wright JLC; Paige M; Strangman WK; Kehn-Hall K Antiviral Res; 2021 Jul; 191():105087. PubMed ID: 33965437 [TBL] [Abstract][Full Text] [Related]
35. The prophylactic and therapeutic activity of a broadly active ribonucleoside analog in a murine model of intranasal venezuelan equine encephalitis virus infection. Painter GR; Bowen RA; Bluemling GR; DeBergh J; Edpuganti V; Gruddanti PR; Guthrie DB; Hager M; Kuiper DL; Lockwood MA; Mitchell DG; Natchus MG; Sticher ZM; Kolykhalov AA Antiviral Res; 2019 Nov; 171():104597. PubMed ID: 31494195 [TBL] [Abstract][Full Text] [Related]
36. Nuclear import and export inhibitors alter capsid protein distribution in mammalian cells and reduce Venezuelan Equine Encephalitis Virus replication. Lundberg L; Pinkham C; Baer A; Amaya M; Narayanan A; Wagstaff KM; Jans DA; Kehn-Hall K Antiviral Res; 2013 Dec; 100(3):662-72. PubMed ID: 24161512 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of Venezuelan Equine Encephalitis Virus Using Small Interfering RNAs. Haikerwal A; Barrera MD; Bhalla N; Zhou W; Boghdeh N; Anderson C; Alem F; Narayanan A Viruses; 2022 Jul; 14(8):. PubMed ID: 35893693 [TBL] [Abstract][Full Text] [Related]
38. Synthetic Host Defense Peptides Inhibit Venezuelan Equine Encephalitis Virus Replication and the Associated Inflammatory Response. Ahmed A; Bakovic A; Risner K; Kortchak S; Der Torossian Torres M; de la Fuente-Nunez C; Lu T; Bhalla N; Narayanan A Sci Rep; 2020 Dec; 10(1):21491. PubMed ID: 33293592 [TBL] [Abstract][Full Text] [Related]
39. Recombinant sindbis/Venezuelan equine encephalitis virus is highly attenuated and immunogenic. Paessler S; Fayzulin RZ; Anishchenko M; Greene IP; Weaver SC; Frolov I J Virol; 2003 Sep; 77(17):9278-86. PubMed ID: 12915543 [TBL] [Abstract][Full Text] [Related]